Olusina Adewale, MD in Dayton, TN - General Practice

Olusina Adewale, MD is a General Practice physician based in Dayton, Tennessee. Olusina Adewale is licensed to practice in Tennessee (license number MD028688) and his current practice location is 7693 Rhea County Hwy, #8, Dayton, Tennessee. He can be reached at his office (for appointments etc.) via phone at (423) 775-8117.

NPI number for Olusina Adewale is 1821133588 and his current mailing address is Po Box 22944, Chattanooga, Tennessee. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1821133588.

Contact Information

	Olusina Adewale, MD
	7693 Rhea County Hwy, #8, Dayton, TN 37321-6082
	(423) 775-8117
	Not Available

Physician's Profile

Full Name	Olusina Adewale
Gender	Male
Speciality	General Practice
Location	7693 Rhea County Hwy, Dayton, Tennessee
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1821133588
Provider Enumeration Date: 02/20/2007
Last Update Date: 11/07/2015

Medical Identifiers

Medical identifiers for Olusina Adewale such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821133588	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	MD028688 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Olusina Adewale is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Olusina Adewale, MD Po Box 22944, Chattanooga, TN 37422-2944 Ph: (423) 485-9008	Olusina Adewale, MD 7693 Rhea County Hwy, #8, Dayton, TN 37321-6082 Ph: (423) 775-8117

News Archive

Intermittent fasting no better for weight loss than eating throughout the day, study finds

As more people become overweight and obese, diet crazes are becoming more popular than ever. One of the most popular diets today is intermittent fasting, an eating pattern that cycles between periods of fasting and eating. Previous studies have tied intermittent fasting to weight loss.

Spring Mountain Capital leads financing round for Oncoceutics with additional private investors' participation

Spring Mountain Capital, LP, a New York-based investment management firm, announced today that its private equity group structured and led a financing round for Oncoceutics, Inc. with additional private investors' participation.

TxCell receives milestone payment of EUR 1 million concerning Ovasave collaboration, license agreement from Trizell

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).

Top-line result from Pfizer Bapineuzumab Phase 3 studies on Alzheimer's

Elan Corporation, plc announced today that Pfizer has issued a top-line result in the first of four Bapineuzumab Phase 3 studies carried out by Pfizer and Janssen AI.

Olusina Adewale, MD - General Practice in Dayton, TN